Rosuvastatin can block pro-inflammatory actions of transgenic human C-reactive protein without reducing its circulating levels.
Šilhavý J, Zídek V, Landa V, Šimáková M, Mlejnek P, Škop V, Oliyarnyk O, Kazdová L, Mancini M, Saar K, Schulz H, Hübner N, Kurtz TW, Pravenec M.
Šilhavý J, et al. Among authors: skop v.
Cardiovasc Ther. 2014 Apr;32(2):59-65. doi: 10.1111/1755-5922.12061.
Cardiovasc Ther. 2014.
PMID: 24410968
Free article.